CDSCO UID IMP/IVD/2022/000065_f1473d18660dab23b638e925c3be9077_e9209845e9871569c83aca1a19684c94Angiotensin Converting Enzyme Control
- UID
- IMP/IVD/2022/000065_f1473d18660dab23b638e925c3be9077_e9209845e9871569c83aca1a19684c94
- Device class
- Class B
- Brand name
- HCY
- License holder
- Genworks Health Pvt Ltd
- Approving authority
- CDSCO
- Product information
- For in vitro diagnostic use in the control of ACE assays on clinical chemistry systems
Angiotensin Converting Enzyme Control is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000065_f1473d18660dab23b638e925c3be9077_e9209845e9871569c83aca1a19684c94. This device is marketed under the brand name HCY. The license holder is Genworks Health Pvt Ltd, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.